Back

Reverse cardiac remodeling effects of sacubitril/valsartan in adults with congenital heart disease

20 May 2023 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - pharmacotherapy 2 Pharmacotherapy HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Andre Paulo Ferreira

Hospital de Santa Marta, Lisbon (Portugal)

6 More presentations in this session

Presentation thumbnail
Aspirin and long-Term risk of heart failure in patients with high atherosclerotic risk
Associate Professor W. Wongcharoen (Chiang Mai, TH)
Abstract Slides
Presentation thumbnail
Efficacy and safety of the dual SGLT1 and 2 inhibitor sotagliflozin in combination with a mineralocorticoid receptor antagonist in patients hospitalized for worsening heart failure
Doctor M. Davies (The Woodlands, US)
Abstract Slides
Presentation thumbnail
Utility of a heart failure treatment score (quad score) in predicting early outcomes in patients with heart failure and a reduced ejection fraction
Doctor B. Li (Basildon, GB)
Abstract Slides
Presentation thumbnail
Use of trimetazidine in myocardial damage by Covid 19 and LVEF recovery.
Doctor R. Rascon Sabido (Veracruz, MX)
Abstract Slides
Presentation thumbnail
Prevalence of sodium glucose co-transporter 2 inhibitor related erythrocytosis (polycythaemia) in real world heart failure patients: a warning for the daily clinical practice
Mr E. Bruwiere ('s-Hertogenbosch, NL)
Abstract Slides

Access the full session

Session thumbnail
ePosters in chronic heart failure - pharmacotherapy 2

The Event

Event poster

Heart Failure 2023

20 May - 23 May 2023
You may be interested in
thumbnail
Congress Presentation
Breaking the barriers in guideline-directed medical therapy implementation in heart failure - discussion
thumbnail
Congress Presentation
The role of ICD therapy in heart failure in 2024. What is the holistic approach to treat heart failure?
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources